Clinical trial
Innovative Strategies For Risk Reduction Following CABG
NCT00462436 · Unity Health Toronto, Other · Completed
Key facts
| NCT number | NCT00462436 |
|---|---|
| Title | Innovative Strategies For Risk Reduction Following CABG |
| Official title | Do Innovative Strategies Complement Medical Management to Reduce Cardiovascular Risk Factors Following Coronary Artery Bypass Graft Surgery? |
| Lead sponsor | Unity Health Toronto, Other |
| Collaborators | Canadian Diabetes Association |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease, Type II Diabetes Mellitus |
| Intervention type | Behavioral |
| Interventions | Consumption of Dietary Portfolio |
| Enrollment | 35 |
| Start date | Feb 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | May 1, 2010 |
| First posted | Apr 19, 2007 |
| Last update posted | Jul 22, 2010 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: